2012

Posters

  • A. GRAMOWSKI, K. JÜGELT, B. M. BADER, O. H.-U. SCHROEDER. In vitro functional assay for the study of additive/synergistic effects of compounds of interest for adjunctive or combination therapy. Program No. 299.05. 2012 Neuroscience Meeting Planner. New Orleans, LA: Society for Neuroscience, 2012. Online.

  • B. M. BADER, E. DEFRANCHI, W. FLEISCHER, A.-M. PIELKA, J. SLOTTA, K. JUEGELT, S. THEISS, S. MARTINOIA, A. NOVELLINO, M. DIHNÉ, O. H. U. SCHRÖDER, A. VOSS1. Embryonic Stem cell-derived progeny for in vitro Screening of compounds that affect Electrically active Neuronal networks. Program No. 33.02. 2012 Neuroscience Meeting Planner. New Orleans, LA: Society for Neuroscience, 2012. Online.

  • K. JÜGELT, B. M. BADER, B. MATZKEIT, M. ZWAR, M. KRIEBEL, H. VOLKMER, G. RICHTER-LEVIN, O. H. U. SCHROEDER, A. VOSS. Fluoxetine induced reversibility of cortical network activity changes induced by butyl-β-carboline-3-carboxylate, pentylenetetrazole or GABAA receptor alpha 1 subunit knockdown: A novel in vitro screening model for compounds with potential for post-traumatic stress disorder. Program No. 664.30. 2012 Neuroscience Meeting Planner. New Orleans, LA: Society for Neuroscience, 2012. Online.

  • B. M. BADER, M. ZWAR, C. FAHRUN, K. JÜGELT, O. H.-U. SCHROEDER, A. VOSS. Functional in vitro characterization of the development of GABAA receptor alpha 1 and 5 subunits in frontal cortex cultures. Program No. 326.08. 2012 Neuroscience Meeting Planner. New Orleans, LA: Society for Neuroscience, 2012. Online.

  • O. H.-U. SCHROEDER, K. JÜGELT, B. M. BADER, A. VOSS. Comparison of orthosteric and allosteric GABAB modulators by their electro-physiological activity patterns on in vitro microcircuits from frontal cortex tissue. Proceedings of EILAT XI, Eilat/Israel.

Talks

  • EBD meeting 14.10.2012 - Hamburg/Germany - Dr. Olaf Schröder, CEO, NeuroProof: "Phenotypic Screenings with Neuronal Network Cultures on Microelectrode Arrays"